CYTOKINES and eicosanoid products of macrophages play an essential role in expression of antitumour activity of macrophages either in a cell-to-cell contact system between the effector and the target cell or as cell-free soluble products. In this review the relationship between three main monokines, namely TNF-, IL-1 and IL-6 and the interrelationship between these monokines and eicosanoids (PGE2, PGI2, LTB4, LTC4) in their production and in expression of antitumour activity is discussed. Emphasis is given to the effect of tumour burden on production of the monokines and of the eicosanoids and on the production of these compounds by the tumour cells.
Introduction
Since the pioneering work of Metchnikoff The main emphasis will be on the role of macrophage cytokines tumour necrosis factor-(TNF-) interleukin-1 (IL-1) and interleukin-6 (IL-6) and on the role of prostaglandin E 2 (PGE2), leukotriene B 4 (LTB4) and leukotriene C4 (LTC4) and their interrelation in the production and expression of antitumour activity. Another aspect (C) 7 and the former LAF was given the name of IL-1 which is still used today. IL-6 was initially described as a factor derived from fibroblasts with antiviral activity. 8 The term was first suggested by Poupart and colleagues 9 and its production by human monocytes was reported. 1 Interactions in the production of macrophage cytokines and eicosanoids
Interactions in production between TNF-, IL-1 and IL- 6: It has been reported that production from blood mononuclear cells and from peritoneal macrophages of TNF-, IL-1 and IL-6, can be induced by the same stimulatory agents. This applies to LPS, >3 phytohaemagglutinin (PHA) and Staphylococcus epidermis. 13 It should be noted also monocytes was also reported by other authors. 26 14 able to stimulate IL-6 synthesis in human blood In spite of the similarities in stimulation of monocytes but not in monocyte derived macrothe production of the monokines, some differences phages whereas TNF-o had no effect on IL-6 were reported in the context of their production, synthesis in monocytes or macrophages. 28 
Human
These differences indicate that mechanisms of their alveolar macrophages and blood monocytes proproduction may be different. Thus, human duced large amounts of IL-6 in response to LPS monocytes stimulated with pneumococcal cell and monocytes produced lesser amounts of IL-6 in surface components produced IL-1 but not response to rIL-1. 29 Monocytes aged in vitro TNF-o. 15 Both protein kinase C (PKc) and produced little detectable IL-6 in response to LPS calmodulin (CAM) kinase dependent pathways or rIL-1, which might suggest that release of IL-6 were found to be involved in the induction of under stimulus is correlated to the degree of IL-1 mRNA by LPS, whereas TNF-expression maturity of macrophage cells. 29 TNF-o or rIL-6 seemed to be PKc dependent but not CaM kinase itself did not modulate IL-6 production in human dependent. 16 Other authors reported that TNF-peripheral blood mononuclear cells. 3 No evidence and IL-1 production andsecretion by mononuclear was found that TNF-o acts to amplify the phagocytes can be modulated differentially. 17 production of IL-6 or IL-1 by murine macrophage Differences between the kinetics of production of cell lines. 31 It was also claimed that synthesis and 46 Recent data suggest that endogenous prostaglandins and leukotrienes do not play a role in the regulation of TNF-production. 47 In addition indomethacin (IND) (a cyclooxygenase inhibitor), exogenous arachidonate and MK-886 (a novel inhibitor of 5-1ipoxygenase product formation) do not affect TNF-production. 47 The interrelationship between TNF-and PGE2 production is also supported by the finding that TNFstimulates PGE2 production in murine resident peritoneal macrophages. 22 Other data indicate that enhancement of TNF-activity may be independent of PGE2 production. Thus 55 In contrast to these data, it was also reported 56 that PGE. had no effect on IL-1 synthesis in murine resident peritoneal macrophages but rather had a direct inhibitory effect on thymocyte proliferation. 5 In spite of the similarities in the stimulating conditions for production of TNF-and IL-1 some differences were also reported. Thus, it was claimed that PGE2 suppresses expression of cell-associated TNF-in murine peritoneal macrophages but had no effect on cell-associated IL-1 activity. 58 
PGE2
suppressed accumulation of TNF mRNA but not of IL-I and 1L-lfl mRNA accumulation. 58 The conclusion from these experiments was that synthesis of TNF appears to be regulated at the level of transcription whereas synthesis of IL-I and IL-lfl is regulated post-transcriptionally. 58 Recently, it was shown that PGE2 inhibits release of TNF-but not of IL-1/8 from human peritoneal macrophages. 42 Interrelation between production of prostaglandins and of IL-1/g in human peritoneal macrophages was recently reexamined, s9 It was found that PGI2 (measured as its stable metabolite 6-keto-PGF=) declined sharply during episodes of peritonitis both in the presence or absence of LPS in the culture medium of human peritoneal macrophages. 59 On the other hand, PGE2 was released in the same amounts in cultures of macrophages collected during peritonitis and during an infection-free period. 59 These results suggest that PGI2 and PGE2 may play a different role in the regulation of IL-lfl production by human macrophages. 59 The production of IL-6 concomitantly to production of PGE2 in LPS-stimulated rat Kupffer cells was examined. 6 and production of PGE. was found. 61 Leukotrienes stimulate production of IL-6 in cultures of human monocytes. 62'63 LTB 4 stimulates production of IL-6 and induces accumulation of IL-6 mRNA. 62'63 Finally, regarding the interrelation between the production of IL-1 and PGE., it was reported that IL-1 and PGE2 are produced by separate subsets of human monocytes. 64 The interrelationship between the production of cytokines and eicosanoids is given in Fig. 2 127 The therapeutic use of TNF-0 in tumour-bearing mice was found to be affected by an increase in the toxicity of TNF-in tumourbearing hosts 6 and by induction of tolerance to TNF-0. 16 A side effect of antibodies to TNF-was reported" passive immunization with anti-TNF antibodies abrogated part.ially IL-2 toxicity in tumour-bearing mice. 162 Finally, the effect of TNF therapy might differ in context to the strain of mice" the curative effect of TNF was stronger against 
